Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyethyleneimine-based gene therapy by inhalation.

Charles L Densmore1

  • 1Department of Molecular Physiology and Biophysics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA. charlesd@bcm.tmc.edu

Expert Opinion on Biological Therapy
|October 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in noninvasive pulmonary gene therapy.

Current drug delivery·2006
Same author

Protection against influenza infection by cytokine-enhanced aerosol genetic immunization.

The journal of gene medicine·2006
Same author

Non-viral gene delivery to the lungs.

Current gene therapy·2005
Same author

Delivery systems for pulmonary gene therapy.

American journal of respiratory medicine : drugs, devices, and other interventions·2004
Same author

Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases.

Clinical cancer research : an official journal of the American Association for Cancer Research·2003
Same author

Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retention.

Molecular therapy : the journal of the American Society of Gene Therapy·2003

Inhaled gene therapy using polyethyleneimine (PEI) shows promise for lung disorders. PEI-based gene delivery via aerosol achieved therapeutic responses in animal models with low toxicity.

Area of Science:

  • Gene therapy
  • Pulmonary medicine
  • Nanotechnology

Background:

  • Inhaled gene delivery offers advantages over invasive methods for treating lung diseases.
  • Early aerosol gene delivery efforts using non-viral vectors faced challenges like nebulization forces and mucus barriers, limiting therapeutic effects.
  • The cloning of the cystic fibrosis gene spurred interest in direct lung gene delivery.

Purpose of the Study:

  • To evaluate the efficacy and safety of polyethyleneimine (PEI)-based gene delivery via aerosol for pulmonary applications.
  • To overcome limitations of previous non-viral vector-based aerosol gene delivery systems.
  • To explore the potential of inhaled gene therapy for treating lung disorders and for localized genetic immunization.

Main Methods:

  • Development and testing of polyethyleneimine (PEI)-based formulations for aerosolized gene delivery.

Related Experiment Videos

  • Assessment of transfection efficiency in airways and lung parenchyma.
  • Evaluation of therapeutic responses in animal lung tumor models using PEI-complexed p53 and IL-12 genes.
  • Analysis of toxicity and CpG immunostimulatory responses.

    • Main Results:

    • PEI-based formulations demonstrated stability during nebulization and high transfection efficiency in airways (nearly 100%).
    • Significant transfection was observed in the lung parenchyma.
    • Therapeutic responses were achieved in animal lung tumor models.
    • The delivery method exhibited low toxicity and minimal CpG immunostimulatory response.

    Conclusions:

    • Aerosolized PEI-based gene delivery is a promising strategy for treating pulmonary diseases, overcoming previous limitations.
    • This approach has demonstrated therapeutic efficacy in preclinical lung cancer models.
    • PEI-based inhaled gene therapy offers a potentially safe and effective platform for both disease treatment and localized genetic immunization.